◀ Back to CDK4
CCND3 — CDK4
Pathways - manually collected, often from reviews:
-
KEGG Cell cycle:
CDKN1B/CDKN1C
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
CDKN1A
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
PCNA
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
CDKN2B
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
→
RBL1/RBL2
(protein-protein, inhibition)
-
KEGG Cell cycle:
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
→
RB1
(protein-protein, inhibition)
-
KEGG Cell cycle:
CDKN2A
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
CDKN2C
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG Cell cycle:
CDKN2D
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
KEGG p53 signaling pathway:
CDKN1A
→
Complex of CCND1-CCND2-CCND3-CDK4-CDK6
(protein-protein, inhibition)
-
NCI Pathway Database Regulation of retinoblastoma protein:
RB1/E2F1-3/DP/HDAC1 complex (RB1-HDAC1-E2F3_E2F2_E2F1-TFDP1)
→
CDK4-6/Cyclin D/p16INK4a complex (CDK6_CDK4-CCND3_CCND2_CCND1-CDKN2A)
(modification, collaborate)
Zhang et al., Cell 2000, Rubin et al., Cell 2005, Kato et al., Genes Dev 1993, Fåhraeus et al., Curr Biol 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
RB1/E2F1-3/DP/HDAC1 complex (RB1-HDAC1-E2F3_E2F2_E2F1-TFDP1)
→
CDK4-6/Cyclin D complex (CDK6_CDK4-CCND3_CCND2_CCND1)
(modification, collaborate)
Zhang et al., Cell 2000, Rubin et al., Cell 2005, Kato et al., Genes Dev 1993, Fåhraeus et al., Curr Biol 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
CDK4-6/Cyclin D/p16INK4a complex (CDK6_CDK4-CCND3_CCND2_CCND1-CDKN2A)
→
HDAC1 (HDAC1)
(modification, inhibits)
Zhang et al., Cell 2000, Rubin et al., Cell 2005, Kato et al., Genes Dev 1993, Fåhraeus et al., Curr Biol 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
CDK4-6/Cyclin D/p16INK4a complex (CDK6_CDK4-CCND3_CCND2_CCND1-CDKN2A)
→
CDK4-6/Cyclin D complex (CDK6_CDK4-CCND3_CCND2_CCND1)
(modification, inhibits)
Zhang et al., Cell 2000, Rubin et al., Cell 2005, Kato et al., Genes Dev 1993, Fåhraeus et al., Curr Biol 1996
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
RB1/E2F1-3/DP/SUV39H1 complex (RB1-SUV39H1-E2F3_E2F2_E2F1-TFDP1)
→
CDK4-6/Cyclin D complex (CDK6_CDK4-CCND3_CCND2_CCND1)
(modification, collaborate)
Vandel et al., Mol Cell Biol 2001
Evidence: assay
-
NCI Pathway Database Regulation of retinoblastoma protein:
p16INK4a (CDKN2A)
→
CDK4-6/Cyclin D/p16INK4a complex (CDK6_CDK4-CCND3_CCND2_CCND1-CDKN2A)
(modification, collaborate)
Fåhraeus et al., Curr Biol 1996
Evidence: physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
p16INK4a (CDKN2A)
→
CDK4-6/Cyclin D complex (CDK6_CDK4-CCND3_CCND2_CCND1)
(modification, collaborate)
Fåhraeus et al., Curr Biol 1996
Evidence: physical interaction
-
NCI Pathway Database Regulation of retinoblastoma protein:
CDK4-6/Cyclin D/p16INK4a complex (CDK6_CDK4-CCND3_CCND2_CCND1-CDKN2A)
→
CDK4-6/Cyclin D complex (CDK6_CDK4-CCND3_CCND2_CCND1)
(modification, collaborate)
Fåhraeus et al., Curr Biol 1996
Evidence: physical interaction
-
WikiPathways Human Thyroid Stimulating Hormone (TSH) signaling pathway:
CDK4
→
CCND3
(activation)
-
WikiPathways Human Thyroid Stimulating Hormone (TSH) signaling pathway:
CCND3
→
CDK4
(activation)
-
WikiPathways miRNA Regulation of DNA Damage Response:
Complex of CDK4-CCND1-CDK6-CCND2-CCND3-CDK5
→
Complex of CDK2-CCNE2-CCNE1
(inhibition)
-
WikiPathways miRNA Regulation of DNA Damage Response:
CDC25A
→
Complex of CDK4-CCND1-CDK6-CCND2-CCND3-CDK5
(activation)
-
WikiPathways DNA Damage Response:
Complex of CDK4-CCND1-CDK6-CCND2-CCND3-CDK5
→
Complex of CDK2-CCNE2-CCNE1
(inhibition)
-
WikiPathways DNA Damage Response:
CDC25A
→
Complex of CDK4-CCND1-CDK6-CCND2-CCND3-CDK5
(activation)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind_translation Interaction:
CDK4
—
CCND3
(array technology)
Ramachandran et al., Science 2004
-
IRef Bind_translation Interaction:
CDK4
—
CCND3
(coimmunoprecipitation)
Laman et al., EMBO J 2005
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
Lin et al., Oncogene 2001*
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
Zhang et al., Endocrinology 1999*
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(direct interaction, two hybrid)
Rual et al., Nature 2005
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
Datta et al., Cell Growth Differ 1998
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
García-Morales et al., Mol Cancer Ther 2006*
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
Bockstaele et al., Mol Cell Biol 2006
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(direct interaction, pull down)
Ramachandran et al., Science 2004
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(direct interaction, two hybrid)
Wang et al., Molecular systems biology 2011
-
IRef Biogrid Interaction:
CDK4
—
CCND3
(physical association, affinity chromatography technology)
Arsenijevic et al., Biochem J 2004*
-
MIPS CORUM CCND3-CDK4 complex:
CCND3-CDK4 complex complex (CCND3-CDK4)
Lundberg et al., Mol Cell Biol 1998*
-
MIPS CORUM CyclinD3-CDK4-CDK6 complex:
CyclinD3-CDK4-CDK6 complex complex (CCND3-CDK4-CDK6)
Wang et al., Cell Growth Differ 1996*
-
MIPS CORUM CyclinD3-CDK4-CDK6-p21 complex:
CyclinD3-CDK4-CDK6-p21 complex complex (CCND3-CDK4-CDK6-CDKN1A)
Wang et al., Cell Growth Differ 1996*
-
IRef Corum Interaction:
Complex of CDKN1A-CDK4-CCND3-CDK6
(association, anti tag coimmunoprecipitation)
Wang et al., Cell Growth Differ 1996*
-
IRef Corum Interaction:
Complex of CCND3-CDK4-CDK6
(association, anti tag coimmunoprecipitation)
Wang et al., Cell Growth Differ 1996*
-
IRef Corum Interaction:
CDK4
—
CCND3
(association, coimmunoprecipitation)
Lundberg et al., Mol Cell Biol 1998*
-
IRef Dip Interaction:
CDK4
—
CCND3
(direct interaction, light scattering)
Takaki et al., Proc Natl Acad Sci U S A 2009*
-
IRef Dip Interaction:
CDK4
—
CCND3
(direct interaction, x-ray crystallography)
Takaki et al., Proc Natl Acad Sci U S A 2009*
-
IRef Dip Interaction:
CDK4
—
CCND3
(direct interaction, molecular sieving)
Takaki et al., Proc Natl Acad Sci U S A 2009*
-
IRef Hprd Interaction:
CCND3
—
CDK4
(in vitro)
Zhang et al., Endocrinology 1999*, Decker et al., Leukemia 2002*, Ramachandran et al., Science 2004
-
IRef Hprd Interaction:
CCND3
—
CDK4
(in vivo)
Zhang et al., Endocrinology 1999*, Decker et al., Leukemia 2002*, Ramachandran et al., Science 2004
-
IRef Intact Interaction:
CDK4
—
CCND3
(direct interaction, protein array)
Ramachandran et al., Science 2004
-
IRef Intact Interaction:
CDK4
—
CCND3
(physical association, anti bait coimmunoprecipitation)
Decker et al., Leukemia 2002*
-
IRef Intact Interaction:
CDK4
—
CCND3
(direct interaction, inferred by curator)
Hermjakob et al., Nucleic Acids Res 2004
-
IRef Intact Interaction:
CDK4
—
CCND3
(physical association, two hybrid pooling approach)
Rual et al., Nature 2005
-
IRef Intact Interaction:
CDK4
—
CCND3
(physical association, two hybrid)
Yu et al., Nat Methods 2011
-
IRef Intact Interaction:
CDK4
—
CCND3
(physical association, two hybrid)
Wang et al., Molecular systems biology 2011
-
IRef Intact Interaction:
CDK4
—
CCND3
(physical association, anti bait coimmunoprecipitation)
LaBaer et al., Genes Dev 1997*
-
IRef Ophid Interaction:
CDK4
—
CCND3
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
-
IRef Ophid Interaction:
CDK4
—
CCND3
(aggregation, confirmational text mining)
Ramachandran et al., Science 2004
Text-mined interactions from Literome
Shimizu et al., Oncogene 2000
(Leukemia, Myeloid, Acute) :
We also showed that an increase in CDK2 bound p27 and
CDK4 bound p18 are caused by treatment with ATRA and a decrease in CDK6 bound
cyclin D3 is
induced synergistically by treatment with both reagents
Coulonval et al., Exp Cell Res 2003
:
In the presence of TSH, transforming growth factor beta ( TGFbeta ) did not affect the assembly of cyclin D3-CDK4, but it strongly inhibited the pRb-kinase activity associated with both cyclin D3 and p27, not only by preventing the nuclear import of
cyclin D3-CDK4 and its binding to p27, but also by
inhibiting CDK4 phosphorylation within residual p27 bound cyclin D3-CDK4 complexes
Hleb et al., J Biol Chem 2004
:
The overall effect of rapamycin on
cyclin D3 leads to impaired formation of active complexes with
Cdk4 or Cdk6 and subsequent inhibition of cyclin D3/CDK kinase activity